Marketing Authorization Application

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

7.633 documents for Marketing Authorization Application

- Cheniere Marketing, LLC; Application for Blanket Authorization To Export Previously Imported Liquefied Natural Gas on a Short-Term Basis
The Office of Fossil Energy (FE) of the Department of Energy (DOE) gives notice of receipt of an application (Application), filed on March 30, 2012, by Cheniere Marketing, LLC (CMI), requesting blanket authorization to export liquefied natural gas (LNG) that previously had been imported into the United States from foreign sources in an amount up to the equivalent of 500 Billion cubic feet (Bcf) of natural gas on a short-term or spot market basis for a two-year period commencing on June 1, 2012. CMI seeks authorization to export LNG from the Sabine Pass LNG terminal, owned by Sabine Pass LNG, L.P., in Cameron Parish, Louisiana, to any country with the capacity to import LNG via ocean- going carrier and with which trade is not prohibited by U.S. law or policy. CMI is requesting this autho...
- Federal Register Nbr. 77 FR 25711, May 01, 2012
- Notices
- Energy Department
- Millennium Announces EMA Acceptance of Marketing Authorization Application for ADCETRIS[TM] (Brentuximab Vedotin).
CAMBRIDGE, Mass. -- Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced t...
- Business Wire
- June 27, 2011
- AMAG Pharmaceuticals and Takeda Announce Acceptance of Submission of Feraheme[R] Marketing Authorization Application to the European Medicines Agency.
Initiated Global Registrational Program for Feraheme for the Treatment of Iron Deficiency Anemia LEXINGTON, Mass. & OSAKA, Japan -- AMAG Pharmaceuti...
- Business Wire
- June 29, 2010

- Human Genome Sciences Announces Submission of Marketing Authorization Application to EMA for BENLYSTA[R] (Belimumab).
ROCKVILLE, Md. -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that GlaxoSmithKline (GSK) has submitted a Marketing Authorization Applic...
- Business Wire
- June 07, 2010
- GPC BIOTECH MARKETING AUTHORIZATION APPLICATION WITHDRAWN.
GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) reported that the company has been informed by its partner for satraplatin in Europe that...
- Worldwide Biotech
- Vol. 20 Nbr. 9, September 2008
- ChemGenex's Marketing Authorization Application for Omacetaxine Mepesuccinate Validated by the European Medicines Agency.
MELBOURNE, Australia & MENLO PARK, Calif. -- ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today that the European Medicines Agency ("EMEA") h...
- Business Wire
- November 27, 2009
- Human Genome Sciences Announces Submission of Marketing Authorization Application to EMEA for JOULFERON[R] (ZALBIN[TM]).
ROCKVILLE, Md. -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Novartis has submitted a Marketing Authorization Application (MAA) t...
- Business Wire
- December 15, 2009
- Sucampo Pharma Europe Submits Marketing Authorization Application in Switzerland.
Sucampo Pharma Europe - Swiss Office Submits Marketing Authorization Application for AMITIZA([R]) to Swissmedic BETHESDA, Md. -- Sucampo Pharmaceuti...
- Business Wire
- June 09, 2008
- Amarin's Marketing Authorization Application for AMR101 to Treat Huntington's Disease Accepted for Review by EMEA.
DUBLIN -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the European Medicines Agency (EMEA) has accepted for review the Company's Marketi...
- Business Wire
- April 08, 2009
- Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe.
AUSTIN, Texas -- Introgen Therapeutics, Inc. (NASDAQ:INGN) and its subsidiary, Gendux Molecular Limited ("Gendux"), announced today the advancement of...
- Business Wire
- November 27, 2007